Human Microbiome Market Size, Share, Growth Analysis, By Product (Drugs, Probiotics), By Disease (Infectious Dieases, Gastrointestinal Diseases), By Type, By End User, By Region - Industry Forecast 2024-2031

Global Human Microbiome Market size was valued at USD 0.8 Billion in 2022 and is poised to grow from USD 1.01 Billion in 2023 to USD 9.7 Billion by 2031, growing at a CAGR of 31.80% during the forecast period (2024-2031).

The human microbiome has recently become an area of interest due to its links to many respiratory and immune systems. The gut microbiome has been linked to a better immune system. Changes in the microbial populations of actinobacteria, firmicutes and bacteroidetes cause lung and respiratory problems. For example, the researchers said that it launched immune-enhancing microbiome therapies to help prevent and combat the new coronavirus (SARS-CoV-2), as well as water-stable tests to help identify patients. Thus, increasing research on microbiota are the major drivers for the growth of this market. The epidemic raises awareness of microbial chemistry and diagnosis. Thus, the market is expected to follow the same trend in the post-pandemic period.

Other major factors driving the growth of this market are increasing burden of lifestyle related diseases and increasing aging population. As according to International Diabetes Association 2021, 52.7 million people aged 20-79 years have diabetes, and the number is expected to reach 69 million in 2045.

The major drivers of the human microbiome market are the increasing application of microbiota in human health applications such as dietary supplementation and dermatology. In addition, technological advances in the microbial industry include next generation based sequencing and widespread use of microbial characterization that can enhance the microbial industry.